Videos

Do you remember Pac-Man, from that old skool computer game? Well, did you know that there are Pac-Mans in every single cell of our body? They're called enzymes. Some of these enzymes work too fast or too slow, and this can cause severe diseases. Michaela Prothiwa (KU Leuven) explains how she wants to track down these malfunctioning enzymes using a clever piece of chemistry.

What if you only had 15 months to live? Hard to imagine, right? Yet every day, around 1,000 people worldwide hear this news. The verdict: glioblastoma, a malignant brain tumor. Yet a small group of patients manages to survive for more than 10 years with such a brain tumor. Brecht Decraene wants to finds out why.

Cancer patients often become heart patients. This is because chemotherapy affects not only cancer cells but also healthy cells, such as the heart muscle cells. In order to prevent heart damage after chemotherapy, we first need to know what factors increase the risk of heart damage. And that is what Sibren Haesen (Uhasselt) has made his mission. With his Ph.D., he wants to help ensure that today's cancer patients do not become tomorrow's heart patients.

Radiation can save the lives of people with head and neck cancer. Unfortunately, many patients develop swallowing disorders as a result of the treatment, which makes it impossible for them to eat solid food. Leen Van den Steen (UAntwerpen - UZA) wants to help them. How? With tongue strength training.

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.

Thanks to new radiotherapy techniques, more and more patients with head and neck cancer are surviving. But for 70% of them, this radiation causes chronic swallowing problems, making it difficult to eat and drink. Hanne Massonet hopes to help them enjoy food and drink again by training their tongue, mouth, and throat muscles.

Have you ever tried to get the last cookie from the bottom of the jar but couldn't quite reach it? Now, what if that cookie can potentially help cure cancer? Wiktoria Wojtaczka (KU Leuven) is investigating terbium, a chemical element that can be turned into a drug for cancer. But the problem she faces in her research is pretty similar to that of the cookie stuck in the jar

Did you know that colon cancer is the third most deadly cancer worldwide? Unfortunately, while immunotherapy is quite effective in the treatment of many cancers, such as skin cancer, it only works in 5% of colon cancer patients. Sara Verbandt (KU Leuven) explains how she wants to make immunotherapy stand up against colon cancer.

Immunotherapy is a very promising therapy for cancer, but only 15 to 30% of the patients respond to this kind of therapy. Giving immunotherapy to patients without knowing whether they will respond is expensive and can even harm them. That's why Madhavi Andhari is looking for markers to tell apart responders from non-responders.

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.

Cracking codes, it's a thing in escape rooms. But it is also what Bénedith Oben tries, albeit in the laboratory. In this way, she hopes to find the key to better understand the development of multiple myeloma, a common blood cancer.

It is a relatively new and promising path in cancer research: the reuse of old, non-cancer drugs. In her PhD, Laurie Freire Boullosa focuses on an old rheumatism pill and examines whether it can be used as a weapon against cancer.